DOBROCAM
- Registration number:ЛП 000141
- International non-proprietary name:bromocamphor
- Pharmaceutical form:tablets
- Pharmacotherapeutic group:sedating medication
- Dosage form:tablets 250 mg No. 30
- Composition:bromocamphor - 250 mg
DOBROCAM is a sedating medication, bromine preparation. Along with other bromides, it can enhance the inhibitory processes in the brain cortex, especially in case of increased excitability of central nervous system. It facilitates natural sleep to begin.
- Indications for use:
-
- increased nervous irritability;
- neurasthenia;
- cardialgia, tachycardia;
- labile blood pressure;
- sleep disorder.
- Method of administration and posology:
-
For oral administration, after meal.
- For adults and children over 14 years old:
1-2 tablets 2-3 times daily;
Maximal daily dose: for adults and children over 14 years old - 1.5 g.
- For adults and children over 14 years old:
-
- For children:
— 7–10 years old — 1 tablet 2 times daily;
Maximal daily dose for children aged 7–10 years — 0.5 g.
— 10–14 years old — 1 tablet 2–3 times daily;
Maximal daily dose for children aged 10–14 years — 0.75 g.Treatment course is 10-15 days.
- For children:
- Shelf life:
-
5 years. Do not use after the expiry date.
- Manufacturer
- OJSC "Irbitsky Chemical-Pharmaceutical Plant"
We recommend
-
Antimicrobial and antiprotozoal agent
-
-
Metabolic agent
-
Enzyme product
-
-
Sedating medication
-
Analgesic agent
-
Antimicrobial agent
-
-
-
Antimicrobial agent
-
Antimicrobial agent
-
Vitamin preparation
-
Combination drug
-
Non-steroidal anti-inflammatory drug (NSAID)
-
-
antiviral agent, aciclovir
-
Antimicrobial and antiprotozoal agent.
-
NOBAZIT®
-
-
Antifungal agent
-
Potassium and magnesium preparation
-
Antifungal agent
-
Spasmolytic agent
-
Combination antimicrobial agent
-
Antimicrobial agent
-
Antifungal agents
-
Coronary dilating drug
-
Antiviral drug
-
-
Enterosorbent.
-
Antimicrobial agent
-
Antiepileptic agent
-
Calcium channel blocker
-
Combination drug